An important feature of the regulatory models built from the inTRINSiC pipeline is that aside from differentiating between different GBM subtypes in terms of the behavior of each TF (Fig 3B), they also provide clues as to the potential mechanisms of the same TF switching regulatory behavior on the same set of target genes (Fig 4). The gene discussed is TF; the disease is glioblastoma.